Cocrystal Pharma(COCP)
BOTHELL, WAPharmaceutical
Focus: Cocrystal Pharma is a public antiviral-focused biotech developing pan-viral inhibitors and targeted treatments for infectious diseases including influenza, hepatitis C, and norovirus. The company operates at clinical-stage with no approved products and minimal cash reserves for a public entity.
Profile data last refreshed 9h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
0
About Cocrystal Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Cocrystal Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Cocrystal Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CDI-988
Healthy VolunteersClinical Trials (1)
NCT05977140CDI-988 Safety Study in Healthy Participants
Phase 1Help build intelligence for Cocrystal Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.